Alphamab Oncology

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG0330A1013
HKD
10.72
0.12 (1.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlphamab Oncology VS Pharmaceuticals & Biotechnology
 
1D
1.13%
1.75%
1W
-2.81%
-0.42%
1M
8.06%
-3.51%
YTD
206.29%
29.5%
1Y
189.73%
27.36%
3Y
-5.3%
33.46%
5Y
-26.07%
-2%
10Y
-26.07%
21.02%
  • Stock Absolute Returns
  • Hang Seng Hong KongAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.83%
0%
-13.83%
6 Months
29.0%
0%
29.0%
1 Year
189.73%
0%
189.73%
2 Years
62.18%
0%
62.18%
3 Years
-5.3%
0%
-5.3%
4 Years
-35.34%
0%
-35.34%
5 Years
-26.07%
0%
-26.07%

Alphamab Oncology for the last several years.

stock-summaryRisk Adjusted Returns v/s Hang Seng Hong Kong
Risk Adjusted Returns v/s stock-summary